JPRN-UMIN000010841已完成未知
Phase 2 trial of Abraxane, albumin-bound paclitaxel, in patients with previously treated non-small cell lung cancer - Phase 2 trial of albumin-bound paclitaxel in patients with previously treated non-small cell lung cancer
niversity of Fukui Hospital0 个研究点目标入组 30 人开始时间: 2013年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with non-small cell lung cancer previously trearted with paclitaxel
研究者
相似试验
招募中
不适用
Phase I open label trial of Abraxane (nab-paclitaxel) administered concurrently with radiotherapy in patients with locally advanced inoperable pancreatic adenocarcinoma.ACTRN12613001013752Southern Adelaide Local Health Network15
已完成
2 期
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerRecurrent Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal CarcinomaNCT00499252Gynecologic Oncology Group51
Unknown
1 期
Abraxane and Temodar Plus Genasense in Advanced MelanomaMelanomaNCT00409383Genta Incorporated28
进行中（未招募）
1 期
Study of Abraxane® and gemcitabine followed by modified FOLFOX in patients with previously untreated, metastatic pancreatic adenocarcinomaMetastatic pancreatic cancerMedDRA version: 18.0Level: LLTClassification code 10033605Term: Pancreatic cancer metastaticSystem Organ Class: 100000004864EUCTR2014-005350-19-ESGrupo de Tratamiento de los Tumores Digestivos (TTD)168
终止
2 期
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With CetuximabHead and Neck CancerNCT00319839University of California, Irvine10